Abstract
Background/Purpose
To study the clinical characteristics, outcomes, and the incidence of postpartum diabetes in women with overt diabetes and GDM.
Methods
This prospective cohort observational study was done on women with GDM diagnosed after the first trimester, attending the tertiary care hospitals for 2.3 years. Comparison of clinical variables and maternal and neonatal outcomes were recorded in women with overt diabetes and GDM. The postpartum glycemic status was determined at 1 and 6 months.
Results
There were 32(17.9%) women with overt diabetes and 146(82.1%) women with GDM. Women with overt diabetes were older, had a higher frequency of pre-pregnancy and maternal obesity, family history of diabetes, previous history of GDM, polycystic ovarian syndrome (PCOS), signs of insulin resistance, and need for insulin treatment than women with GDM. The prevalence of gestational hypertension and frequency of spontaneous abortion and large for gestational age (LGA) neonates were significantly higher in women with overt diabetes than in GDM, despite comparable glycemic goals. Postpartum diabetes at 1 and 6 months was significantly higher in women with overt diabetes than in those with GDM.
Conclusion
It is critical to identify women with overt diabetes in pregnancy because of increased risk of adverse maternal and neonatal outcomes, and rapid progression to postpartum diabetes, despite achieving optimal glycemic goals.
Similar content being viewed by others
References
Metzger BE, Lowe LP, HAPO Study Cooperative Research Group, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S13-S33.
Metzger BE, Gabbe SG, International Association of Diabetes and Pregnancy Study Groups Consensus Panel, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.
Wong T, Ross GP, Jalaludin BB, et al. The clinical significance of overt diabetes in pregnancy. Diabet Med. 2013;30(4):468–74.
Bhavadharini B, Anjana RM, Mahalakshmi MM, et al. Glucose tolerance status of Asian Indian women with gestational diabetes at 6 weeks to 1 year postpartum (WINGS-7). Diabetes Res Clin Pract. 2016;117:22–7.
Mukerji G, Chiu M, Shah BR. Impact of gestational diabetes on the risk of diabetes following pregnancy among Chinese and South Asian women. Diabetologia. 2012;55(8):2148–53.
Gupta Y, Kapoor D, Desai A, et al. Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort. Diabet Med. 2017;34(1):37–43.
Krishnaveni GV, Hill JC, Veena SR, et al. Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res Clin Pract. 2007;78(3):398–404.
Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol. 2011;118(6):1379–93.
Sampaio Y, Porto LB, Lauand TC, et al. Gestational diabetes and overt diabetes first diagnosed in pregnancy: characteristics, therapeutic approach and perinatal outcomes in a public healthcare referral center in Brazil. Arch Endocrinol Metab. 2021;65(1):79–84.
Mañé L, Flores-Le Roux JA, Benaiges D, et al. Impact of overt diabetes diagnosed in pregnancy in a multi-ethnic cohort in Spain. Gynecol Endocrinol. 2019;35(4):332–6.
Li MF, Ma L, Yu TP, et al. Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism. Diabetes Res Clin Pract. 2020;161:108085.
Wali AS, Rafique R, Iftikhar S, et al. High proportion of overt diabetes mellitus in pregnancy and missed opportunity for early detection of diabetes at a tertiary care centre in Pakistan. Pak J Med Sci. 2020;36(1):S38–43.
Sugiyama T, Saito M, Nishigori H, et al. Comparison of pregnancy outcomes between women with gestational diabetes and overt diabetes first diagnosed in pregnancy: a retrospective multi-institutional study in Japan. Diabetes Res Clin Pract. 2014;103(1):20–5.
Park S, Kim S-H. Women with rigorously managed overt diabetes during pregnancy do not experience adverse infant outcomes but do remain at serious risk of postpartum diabetes. Endocr J. 2015;62:319–27.
Weight Gain during pregnancy. Committee Opinion No. 548. American college of obstetricians and gynecologists. Obstet Gynecol. 2013;121(1):210-2.
American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S200-S210.
Seshiah V, Balaji V. Diabetes and pregnancy (gestational diabetes). In: Tripathy BB, Chandalia HB, editors. RSSDI textbook of diabetes mellitus. 2nd ed. New Delhi: RSSDI; 2008. p. 1060–79.
Immanuel J, Eagleton C, Baker J, et al. Pregnancy outcomes among multi-ethnic women with different degrees of hyperglycaemia during pregnancy in an urban New Zealand population and their association with postnatal HbA1c uptake. Aust N Z J Obstet Gynaecol. 2021;61(1):69–77.
Coustan DR, Berkowitz RL, Hobbins JC. Tight metabolic control of overt diabetes in pregnancy. Am J Med. 1980;68(6):845–52.
Goyal A, Gupta Y, Kalaivani M, et al. Long term (> 1 year) postpartum glucose tolerance status among Indian women with history of gestational diabetes mellitus (GDM) diagnosed by IADPSG criteria. Diabetes Res Clin Pract. 2018;142:154–61.
Jindal R, Siddiqui MA, Gupta N, et al. Prevalence of glucose intolerance at 6 weeks postpartum in Indian women with gestational diabetes mellitus. Diab Met Syndr: Clin Res Rev. 2015;9(3):143–6.
Acknowledgments
The authors would like to express their greatest gratitude to all participating patients, health professionals, and community support group members, who provided assistance for this study. I also thank the technical department of Endocrinology and Obstetrics.
Funding
Nil.
Author information
Authors and Affiliations
Contributions
TN designed the study, supervised the work, and reviewed the article. TN, NR, QAA, and SM collectively did the literature search. TN and SM conducted the clinical studies. TN, NR, and QAA did the data analysis. TN and QAA performed statistical analysis. TN, NR, QAA, and SM worked together to write the article and edit and critical revisions of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest to be declared.
Ethical Approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the institutional ethical committee.
Informed Consent
Informed consent was obtained from all the participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nabi, T., Rafiq, N., Arifa, Q.A. et al. Effect of Overt Diabetes and Gestational Diabetes Mellitus on Pregnancy Outcomes and Progression. J Obstet Gynecol India 72 (Suppl 1), 235–242 (2022). https://doi.org/10.1007/s13224-022-01649-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-022-01649-4